作者: Petra Hamerlik
DOI:
关键词: VEGFR2 Antagonist 、 Cancer research 、 Progenitor cell 、 Biology 、 Cancer 、 Pathology 、 VEGF receptors
摘要: The present invention relates to the field of diagnosis and treatment hyperproliferative diseases, such as cancer. In particular, methods identifying killing cancer stem-like cells and/or progenitor using compounds capable associating with VEGFR2 NRP-1. Furthermore, identification useful for cells, said being antagonists NRP-1 antagonists. does also relate patients that are sensitive antagonist hence would benefit from according